{
    "Table 1": "Optimization of the reaction conditions.[a]",
    "Table 2": "Substrate scope of arylboronic acids in electrochemical deborylative hydroxylation.[a]",
    "Table 3": "Experimental mechanistic studies",
    "Scheme 1": "Established and desired transformations of arylboronic acids in our group",
    "Scheme 2": "1,4-Benzenediol generated from electrochemical deborylative conversion of 4-hydroxyphenylboronic acid (26) orp-phenylenediboronic acid (26\u2032)",
    "Scheme 3": "Electrochemical deborylative hydroxylation of arylboronic acid pinacol (BPin) esters (1\u2032and15\u2032) and aryltrifluoroborates (1\u2032\u2032and15\u2032\u2032). [a] Conditions:1\u2032(0.2\u2005mmol),nBu4NBF4(1\u2005equiv.),N,N-DMEDA (4\u2005equiv.), MeCN (10\u2005mL) in an undivided cell with CC (1.0\u00d71.0\u2005cm2) anode and cathode, O2(1\u2005atm), rt, 6\u2005mA, 3\u2005h; [b] conditions:1\u2032\u2032(0.2\u2005mmol),nBu4NBF4(1\u2005equiv.),N,N-DMEDA (4\u2005equiv.), MeCN/H2O (2\u2009:\u20091, 15\u2005mL) in an undivided cell with CC (1.0\u00d71.0\u2005cm2) anode and cathode, O2(1\u2005atm), rt, 3\u2005mA, 3\u2005h; [c] conditions:15\u2032(0.2\u2005mmol),nBu4NBF4(1\u2005equiv.),iPr2NEt (4\u2005equiv.), MeCN (10\u2005mL) in an undivided cell with CC (1.0\u00d71.0\u2005cm2) anode and cathode, O2(1\u2005atm), rt, 3\u2005mA, 3\u2005h; [d] conditions:15\u2032\u2032(0.2\u2005mmol),nBu4NBF4(1\u2005equiv.),iPr2NEt (4\u2005equiv.), MeCN/H2O (2\u2009:\u20091, 15\u2005mL) in an undivided cell with CC (1.0\u00d71.0\u2005cm2) anode and cathode, O2(1\u2005atm), rt, 3\u2005mA, 3\u2005h",
    "Scheme 4": "Preparation of drug molecules (27-30\u2009p) and scale-up synthesis (28\u2009p). [a] Conditions:28(5\u2005mmol),nBu4NBF4(1\u2005equiv.),N,N-DMEDA (4\u2005equiv.), MeCN (200\u2005mL) in an undivided cell with CC (1.5\u00d71.5\u2005cm2) anode and cathode, O2(1\u2005atm), rt, 6\u2005mA, 48\u2005h",
    "Figure 1": "Cyclic voltammograms of substrate and additive in MeCN under aerobic conditions: [a]nBu4NBF4(0.1\u2005mol\u2009L\u22121); [b] 4-methoxyphe-nylboronic acid (0.1\u2005mol\u2009L\u22121) andnBu4NBF4(0.1\u2005mol\u2009L\u22121); [c]N,N-DMEDA (0.4\u2005mol\u2009L\u22121) andnBu4NBF4(0.1\u2005mol\u2009L\u22121); [d]nBu4NBF4(0.1\u2005mol\u2009L\u22121) in H2O/MeCN (0.05\u2009:\u200910, 10.05\u2005mL) mixed solvents",
    "Scheme 5": "Proposed mechanism"
}